ATAI Life Sciences NV (MEX:ATAI) Days Sales Outstanding : 0.00 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ATAI Life Sciences NV Days Sales Outstanding?

ATAI Life Sciences NV's average Accounts Receivable for the three months ended in Jun. 2024 was MXN0.00 Mil. ATAI Life Sciences NV's Revenue for the three months ended in Jun. 2024 was MXN5.00 Mil. Hence, ATAI Life Sciences NV's Days Sales Outstanding for the three months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for ATAI Life Sciences NV's Days Sales Outstanding or its related term are showing as below:

MEX:ATAI's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.685
* Ranked among companies with meaningful Days Sales Outstanding only.

ATAI Life Sciences NV's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

ATAI Life Sciences NV Days Sales Outstanding Historical Data

The historical data trend for ATAI Life Sciences NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Days Sales Outstanding Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of ATAI Life Sciences NV's Days Sales Outstanding

For the Biotechnology subindustry, ATAI Life Sciences NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ATAI Life Sciences NV's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's Days Sales Outstanding falls into.

ATAI Life Sciences NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ATAI Life Sciences NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	5.33	*	365
=	0					/	5.33	*	365
=	0.00

ATAI Life Sciences NV's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	5.001	*	365 / 4
=	0					/	5.001	*	365 / 4
=	0.00

ATAI Life Sciences NV (MEX:ATAI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ATAI Life Sciences NV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ATAI:USA 9VC:Germany 9VC:Germany 9VC:Germany

Address

Wallstrasse 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.